BHC Bausch Health Companies Inc.

NYSE bauschhealth.com


$ 6.02 $ -0.01 (-0.17 %)    

Thursday, 16-Oct-2025 15:59:58 EDT
QQQ $ 599.27 $ -2.23 (-0.37 %)
DIA $ 459.11 $ -3.15 (-0.68 %)
SPY $ 659.59 $ -4.53 (-0.68 %)
TLT $ 91.35 $ 0.68 (0.75 %)
GLD $ 400.72 $ 9.06 (2.34 %)
$ 6.01
$ 6.02
$ 5.96 x 10
$ 6.15 x 245
$ 5.89 - $ 6.12
$ 4.25 - $ 9.85
1,399,098
na
2.22B
$ 0.98
$ 22.68
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-19-2020 12-31-2019 10-K
24 11-04-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-06-2019 03-31-2019 10-Q
27 02-20-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-01-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 06-07-2016 03-31-2016 10-Q
39 04-29-2016 12-31-2015 10-K
40 10-26-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical comp...

 billionaire-investor-buys-google-and-this-gold-miner-stock

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

 icahn-hedge-funds-q2-moves-centuri-stake-soars-jetblue-held-2-positions-exited

Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names ...

Core News & Articles

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulso...

 carl-c-icahn-dissolves-stake-in-bausch-health-companies-as-of-aug-14-vs-prior-stake-of-94-as-of-may-20

https://www.sec.gov/Archives/edgar/data/885590/000153949725002158/xslSCHEDULE_13D_X01/primary_doc.xml

Core News & Articles

Recent business highlights and updates:In July 2025, DURECT announced that it entered into an Agreement and Plan of Merger with...

 bausch-health-companies-q2-adj-eps-091-misses-096-estimate-sales-2530b-beat-2481b-estimate

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate o...

 bausch-health-companies-raises-fy2025-sales-guidance-from-9950b-10200b-to-10000b-10250b-vs-10023b-est

Bausch Health Companies (NYSE:BHC) raises FY2025 sales outlook from $9.950 billion-$10.200 billion to $10.000 billion-$10.250 b...

 bausch-health-companies-q2-sales-2530b-beat-2481b-estimate

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.530 billion which beat the analyst consensus estimate of $2.4...

 bausch-health-adds-late-stage-ready-alcohol-liver-disease-drug-candidate-in-63-million-durect-buyout

Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via P...

Core News & Articles

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the...

Core News & Articles

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindam...

 bausch-health-companies-13d-filing-shows-paulson--co-inc-reports-89-stake-in-co-as-of-june-13-vs-71-as-of-may-20

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION